By combining our biomarker technologies with our expertise in preclinical and clinical research, we can identify drug candidates most likely to benefit patients. The identification of predictive and prognostic biomarkers enriches clinical trials, which can reduce trial length and size of studies required to determine therapeutic efficacy.
Our services glean insights into pharmacodynamics, response-to-treatment, mode-of-action investigation, and much more. Our approach is highly scientific, and we are proud to publish our results frequently in leading journals worldwide.
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.